Successes, challenges, and controversies of diagnostic methods for APS
A Catalyst for Antiphospholipid Syndrome Research
APS ACTION is coordinating international efforts to study this rare and potentially fatal autoimmune disorder
Antiphospholipid Syndrome
Antiphospholipid syndrome (APS) is an autoimmune disease associated with frequent clotting in arteries and veins and fetal losses. The clotting results from the presence of proteins in the blood—called antiphospholipid autoantibodies (aPL)—formed against the person’s own tissues.
Antiphospholipid Antibody Syndrome
A recently identified autoimmune disorder, antiphospholipid antibody syndrome (APS) mainly affects young women between age 30 and 40. Those affected by APS may otherwise be healthy or have an underlying disease such as systemic lupus erythematosus (SLE).
Put Hughes Syndrome on Your Radar
Diagnosis of antiphospholipid syndrome is increasing. Here’s how to recognize and treat it